You Are Here: Home > Researchers > Admin

Host institution/Arthritis Society agreement

Host institution/Arthritis Society agreement

In the event that the Principal Investigator (and all others who participate as a result) is awarded a grant (refers to any form of funding to a Host Institution or other recipient) with funds administered by Arthritis Society Canada then for value received, the undersigned Host Institution agrees that the Institution shall provide adequate physical and organizational infrastructure for the conduct of the research, research training, and other activities funded by Arthritis Society Canada, and:

  1. Any grant that may be awarded shall be administered in accordance with the Regulations set forth on the Arthritis Society Canada research website. Grants awarded are made only upon the approval of Arthritis Society Canada. All grants are at all times conditional upon and subject to, availability of funds to Arthritis Society Canada. In addition, Arthritis Society Canada reserves the right to terminate, at any time and without cause, any grant.

  2. Any proposed clinical investigation involving experimentation in human subjects has been or shall be examined by the appropriate Host Institution(s) committee(s) and found to be acceptable from an ethical point of view in accordance with the TCPS 2 - Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans, published by the Canadian Institutes for Health Research, the Natural Sciences and Engineering Research Council of Canada and the Social Sciences and Humanities Research Council of Canada.

  3. Any proposed investigation involving the use of experimental animals has been or shall be examined by the appropriate Institutional Animal Care Committee(s) and found to be acceptable as far as the experimental procedures and the continuing care of these animals are concerned, in accordance with the Canadian Council on Animal Care guidelines.

  4. Any proposed investigation involving the use of biological materials has been or shall be found acceptable by the appropriate Institutional Biohazards Committee(s) and will be conducted under conditions which satisfy the Laboratory Biosafety Guidelines published by the Canadian Institutes of Health Research and Health Canada.

  5. Any proposed investigation involving human samples has been or shall be collected in accordance with recognized standards, or shall include a description of the source, quality and handling procedures.

  6. The Host Institution(s) within which the research will be conducted maintains or shall develop during the term of any grant a policy on inventions and patents which applies to the Principal Investigator and which does not require Arthritis Society Canada to assume any responsibility for any costs, expenses or liabilities relating to inventions or patents.

  7. The Host Institution(s) accepts responsibility for:

    • Investigating possible instances of misconduct in research or scholarship;

    • Imposing appropriate sanctions in accordance with their own policies;

    • Informing Arthritis Society Canada of conclusions reached and actions taken, including decisions involving Co-applicants from other institutions where there is more than one institution involved; and

    • Any and all actions taken or omitted to be taken by it, or the Principal Investigator as applicable.

    The Host Institution agrees that in cases in which misconduct or any other breach of the obligations owed by the Host Institution(s) to Arthritis Society Canada has occurred, Arthritis Society Canada may impose its own sanctions as set out in the policy statement on the Arthritis Society Canada website or take such other actions as Arthritis Society Canada may determine.

  8. The Host Institution(s) accepts responsibility for issuing a “Statement of Account” on an annual basis, for each grant being administered under its authority. The Host Institution(s) must provide regular information to the PI regarding their account.

  9. None of Arthritis Society Canada, their associates, or their respective directors, officers, agents, members, employees or representatives shall be liable for any loss, injury, damage or any other liabilities whatsoever to persons or property due to or arising out of the said research, either directly or indirectly, whether attributable to negligence or otherwise, including any loss, injury, damage or liabilities to the health or well-being of any research subject or innocent bystander or any loss, injury, damage or any other liability whatsoever to an agent, employee or representative of the Host Institution or Principal Investigator.
    The Host Institution agrees to indemnify and save harmless Arthritis Society Canada, their associates and their respective directors, officers, agents, members, employees and representatives (individually an “Indemnitee”) from and against:

    • (i) all claims, damages, losses, costs, expenses, liabilities or demands of any nature whatsoever which an Indemnitee sustains (or may sustain) including in respect of or in connection with any claim, action, proceeding or any other circumstance which is alleged, threatened, commenced or prosecuted, for or in respect of any act (or inaction or omission), deed, matter or thing whatsoever, made, done or permitted to be done by the Host Institution(s) directly or indirectly including by the Principal Investigator or any other party, whether attributable to negligence or otherwise arising out of or by virtue of its having granted funds for research to the Host Institution(s), Principal Investigator or the Host Institution(s), in respect of its having acted or omitted to act in connection with such research; and

    • (ii) all other costs, charges and expenses, including legal fees and expenses on a substantial indemnity basis, whether such costs, charges and expenses relate to the forgoing damages, claims, liabilities, demands or otherwise, which an Indemnitee sustains or incurs in or about or in relation to the research.

  10. The person named as the Principal Investigator remains the Principal Investigator on a grant for the duration of the grant unless given express permission by Arthritis Society Canada. In addition, if the eligibility of the PI changes over the term of the grant, Arthritis Society Canada must be informed immediately.

  11. Host Institution(s) shall ensure the Principal Investigator advises all others named and working on the grant of the regulations of Arthritis Society Canada, including the policies regarding inventions and patents and misconduct.

  12. Arthritis Society Canada must be acknowledged for public announcements of a grant, publications or presentations, in the format described in the Notification of Award.

  13. Grantees and their host institutions must acknowledge Arthritis Society Canada (and/or Arthritis Society Canada partner/donor, as appropriate) in all materials, communications and media releases related to the funded work.

Contravention of Arthritis Society Canada policies, as applicable, by the Host Institution(s), Principal Investigator or any others may result in consequences including the immediate termination of a grant, return of any funds already disbursed and the requirement of the Host Institution(s) to compensate Arthritis Society Canada for any and all costs, expenses and other amounts.